FDA approves Roche’s Lunsumio VELO™ for subcutaneous use in relapsed or refractory follicular lymphoma

Lunsumio VELO reduces administration time from 2-4 hours to approximately one minuteAvailability of Lunsumio VELO allows treatment aligned to people’s clinical needs and personal preferences Approval ...

JBD Launches "Roadrunner I" Polychrome Projector, Setting a New Benchmark for AR Color Displays with a 2.5μm Pixel Pitch

Global MicroLED microdisplay technology leader JBD has officially launched the "Roadrunner I" polychrome projector. As the inaugural product of the new "Roadrunner" series, "Roadrunner I" not only ...